Health Tech Capitol | Gregor Diagnostics gets financial push toward a new test for prostate cancer
16265
post-template-default,single,single-post,postid-16265,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Gregor Diagnostics gets financial push toward a new test for prostate cancer

22 Jul Gregor Diagnostics gets financial push toward a new test for prostate cancer

Posted at 14:02h in Uncategorized by
0 Likes

Gregor Diagnostics, a Madison startup working on a new way to screen men for prostate cancer, is getting a $900,000 financial boost from investors around the country, paving the way for the company’s first patient study.

Gregor, founded in 2016, is developing a home test kit for prostate cancer — believed to be the first of its kind. Prostate cancer is the second leading cause of cancer deaths for men in the U.S., the National Cancer Institute says.

Tobias Zutz, founder, CEO and currently the sole employee of Gregor, said checking a semen sample for certain biomarkers should be a more informative analysis than a blood test, which is the most common way to screen for prostate cancer now.

Much like Exact Sciences’ Cologuard home test kit analyzes stool samples for colorectal cancer, Gregor’s test aims to look at the fluid closest to the source of the disease.

Read more at the Wisconsin State Journal

No Comments

Sorry, the comment form is closed at this time.